Scrip
Biogen Idec reiterates bid for Facet despite second rejection
09 September 2009
Sita Shah
Please Login to read the full article.
09 September 2009
Sita Shah
sita.shah@informa.com
Biogen Idec has reiterated its $14.50 per share, all-cash offer for Facet Biotech after Facet rejected the offer for a second time. Investors welcomed the move by Facet as the company's share price rose by 5% to close at $16.15 yesterday.
Last month, Facet rejected a $15 per share offer...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Roche's Asian partnering head looks to tap regional innovation
- Face-to-Face: Trophos - The French firm that hooked Actelion
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
